| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.4M | -21.9% |
| Cost of Revenue | $6.3M | -22.9% |
| Gross Profit | $1.1M | -15.8% |
| R&D Expense | $51K | +6.6% |
| SG&A Expense | $1.5M | -22.2% |
| Operating Income | -$3.0M | -88.4% |
| Pre-tax Income | -$3.0M | -87.1% |
| Income Tax | $0 | +100.0% |
| Net Income | -$3.0M | -86.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.5M | -13.9% |
| Accounts Receivable | $506K | -63.3% |
| Inventory | $677K | -51.3% |
| Current Assets | $5.4M | -26.7% |
| Total Assets | $9.3M | -11.3% |
| Current Liabilities | $521K | -73.3% |
| Total Liabilities | $638K | -69.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | +17.7% |
| Capital Expenditures | $37K | -83.7% |
| Investing Cash Flow | $945K | +125.9% |
| Financing Cash Flow | $299K | +106.1% |
| Free Cash Flow | -$1.9M | +23.8% |
| $8.6M |
| +3.5% |